New York Oncology Heamatology - Latham — Clifton Park, New York

New York Oncology Heamatology - Latham is a clinical research site located in Clifton Park, New York, United States 12065.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Heamatology - Latham has participated in 1 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer.

Sponsors: Eisai Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Heamatology - Latham?

New York Oncology Heamatology - Latham has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Heamatology - Latham conducted?

New York Oncology Heamatology - Latham has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer.

Is New York Oncology Heamatology - Latham accredited by Crixeo Health?

New York Oncology Heamatology - Latham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Heamatology - Latham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.